The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Headquartered in Rock Hill, South Carolina with offices in Colorado, Tennessee, Oregon and Seattle, 3D Systems Corp. DDD assists manufacturers with prototypes, models, tooling patterns and additional parts for mass assembly. 3D also holds a special place in the printing industry due to its On Demand part printing service, 3D printers, the development of stereolithography and creation of the STL format.
3D Systems DDD Up 30.85%
DDD is up $8.91 today to just under $38 at press time. This time last year, the stock sat at around $11, steadily rising as high as $55, dropping to around $30 and rising once again to the $38 range. In the previous week, the stock remained flat prior to a significant announcement.
Why is DDD Moving?
3D Systems and CollPlant are gaining traction after an announcement that the two plan to develop a regenerative soft tissue matrix, useful for breast reconstruction. Because the overall outlook for the medical industry is positive, additional medical technology is naturally increasing DDD’s value.
Where to Buy 3D Systems Stock
When you want to buy DDD stock, you also need to know where to open a brokerage account. Use the list below to find the best broker, the most enjoyable experience and potentially the greatest profits.
Broker |
Best For |
Overall Rating |
Start Trading |
Intermediate Traders |
4.5 Stars |
||
Lowest Fees |
5 Stars |
||
Beginner Traders |
4 Stars |
||
Active Traders |
5 Stars |
||
Day Traders |
5 Stars |
Stay Ahead of the Game on DDD
When you want to stay ahead of the game, use Benzinga Pro to track trending stocks, review their performance and gather all the information you need to turn a profit. With Benzinga, you can make informed decisions on any stock — including DDD!
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.